July 2018
Volume 59, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2018
Common Variants in KLHL2 and C4orf50 Are Associated with Poorer Anti-VEGF Treatment Response in Age-Related Macular Degeneration
Author Affiliations & Notes
  • Omar García Rodríguez
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • Samuel Shuoyuan Pan
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • Patrice Patrice
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • Larry D. Adams
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • Jacob Welch
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • Renee Laux
    Population & Quantitative Health Science, Case Western Reserve University, Cleveland , Ohio, United States
  • Jorge Fortun
    Bascom Palmer Eye Institute, University of Miam, Miami, Florida, United States
  • Milam A Brantley
    Ophthalmology & Visual Sciences, , Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Jaclyn Kovach,
    Bascom Palmer Eye Institute, University of Miam, Miami, Florida, United States
  • Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miam, Miami, Florida, United States
  • Anita Agarwal
    West Coast Retina, West Coast Retina, San Francisco, California, United States
  • Jonathan Haines
    Population & Quantitative Health Science, Case Western Reserve University, Cleveland , Ohio, United States
  • Margaret A Pericak-Vance
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • William Scott
    Hussman Institute , Univestiy of Miami , Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Omar García Rodríguez, None; Samuel Shuoyuan Pan, None; Patrice Patrice, None; Larry Adams, None; Jacob Welch, None; Renee Laux, None; Jorge Fortun, None; Milam Brantley, None; Jaclyn Kovach,, None; Stephen Schwartz, Alimera (I), Welch Allyn (I); Anita Agarwal, None; Jonathan Haines, None; Margaret Pericak-Vance, None; William Scott, None
  • Footnotes
    Support  T32 EY023194
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1425. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Omar García Rodríguez, Samuel Shuoyuan Pan, Patrice Patrice, Larry D. Adams, Jacob Welch, Renee Laux, Jorge Fortun, Milam A Brantley, Jaclyn Kovach,, Stephen G Schwartz, Anita Agarwal, Jonathan Haines, Margaret A Pericak-Vance, William Scott; Common Variants in KLHL2 and C4orf50 Are Associated with Poorer Anti-VEGF Treatment Response in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1425.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Response to anti-vascular endothelial growth factor(anti-VEGF) treatment in people with choroidal neovascularization (CNV) is variable. Candidate gene and genome-wide association studies (GWAS) of treatment response have produced inconsistent results. To better elucidate genetic factors underlying treatment response, we conducted a GWAS for one-year change in visual acuity in individuals with CNV treated with anti-VEGF therapy.

Methods : We studied 90 non-Hispanic whites with CNV (107 eyes) treated monthly for the first three months and as needed afterward and followed for at least one year at Bascom Palmer Eye Institute or Vanderbilt Eye Institute. Samples were genotyped using the Illumina CoreExome Array and imputed against the 1000 Genomes reference panel. All visual acuity values were transformed into Logarithm of the Minimum Angle Resolution(logMAR). Change in logMAR over one year(ΔlogMAR) was selected as the endpoint. Patients with positive values had worse vision and those with zero or negative values had stable or improving vision at one year. A linear mixed model evaluated the association of ΔlogMAR and single nucleotide polymorphism dosage, adjusted for age, sex, treatment [bevacizumab,ranibizumab or aflibercept], and correlation of paired eyes. A p-value less than 5x10-8 was considered statistically significant. Institutional Review Boards approved the protocol at each institution.

Results : The sample was 58% female (n=52) and the mean age was 80 (range: 55-98). There were two regions on chromosome 4 with genome wide significant association, near C4orf50 and KLHL2. Each additional T allele at rs116641154 in C4orf50 was associated with a mean 0.4 increase in ΔlogMAR at one year (±0.07; p=3.16x10-8), representing worsening visual acuity. A similar effect was observed in A allele carriers at rs79399888 in KLHL2. Participants with this allele had a mean 0.58 increase in ΔlogMAR at one year(±0.1; p=1.14X10-9).

Conclusions : We identified two new loci associated with worse anti-VEGF treatment response evidences that mechanisms governing risk of AMD and response to treatment may be distinct. If confirmed by additional studies, these results could be used to identify individuals at risk of poorer treatment response, and these individuals could be prioritized for new treatments or altered therapeutic regimens.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×